drugset / Trial / NCT00466947

COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & Acute Otitis Media (AOM ) Efficacy Study of the Pneumococcal Conjugate Vaccine

NCT00466947

Phase 3 Completed 23802 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindPrevention

Summary

This is a study in a large number of healthy children less than 3 years old to measure the efficacy of GlaxoSmithKline (GSK) Biologicals' 10-valent pneumococcal conjugate candidate vaccine (Synflorix vaccine, or GSK1024850A) to prevent cases of pneumonia (lung infection) likely caused by bacteria (Streptococcus pneumoniae and Haemophilus influenzae) or cases of otitis media (ear infection) in children under 3 years old.

Timeline

Start
2007-06-28
Primary completion
2010-08-31
Completion
2011-07-28

Drugs

EvaluationDrugModalityDoseRoute
Subject GSK Biologicals' DTPa-IPV/Hib vaccine Vaccine Intramuscular
Subject GSK1024850A Vaccine Intramuscular
Subject Havrix Vaccine Intramuscular
Comparator Engerix-B Vaccine Intramuscular
Background Infanrix hexa Vaccine Intramuscular